Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Good

Showing results (271-280 of 291) with videos related to

Pageof 30
Sort By:
Science (New York, N.Y.)|April 12, 2008
Aligning conservation priorities across taxa in Madagascar with high-resolution planning toolsC Kremen, A Cameron, A Moilanen, et al.
Journal of Medicinal Chemistry|October 4, 2012
Acyl guanidine inhibitors of β-secretase (BACE-1): optimization of a micromolar hit to a nanomolar lead via iterative solid- and solution-phase library synthesisSamuel W Gerritz, Weixu Zhai, Shuhao Shi, et al.
Journal of Medicinal Chemistry|October 15, 2016
Identification of (R)-N-((4-Methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide (CPI-1205), a Potent and Selective Inhibitor of Histone Methyltransferase EZH2, Suitable for Phase I Clinical Trials for B-Cell LymphomasRishi G Vaswani, Victor S Gehling, Les A Dakin, et al.
ACS Medicinal Chemistry Letters|February 20, 2018
Potent Inhibitors of Hepatitis C Virus NS3 Protease: Employment of a Difluoromethyl Group as a Hydrogen-Bond DonorBarbara Zheng, Stanley V D'Andrea, Li-Qiang Sun, et al.
Journal of Medicinal Chemistry|November 24, 2025
Discovery of CFT8634, a Potent, Selective, and Orally Bioavailable Heterobifunctional Degrader of BRD9Katrina L Jackson, Ning Yin, Roman V Agafonov, et al.
Bioorganic & Medicinal Chemistry Letters|October 7, 2011
Synthesis and in vivo evaluation of cyclic diaminopropane BACE-1 inhibitorsLorin A Thompson, Jianliang Shi, Carl P Decicco, et al.
Journal of Medicinal Chemistry|August 5, 2022
GNE-064: A Potent, Selective, and Orally Bioavailable Chemical Probe for the Bromodomains of SMARCA2 and SMARCA4 and the Fifth Bromodomain of PBRM1Alexander M Taylor, Chris Bailey, Lisa D Belmont, et al.
The Journal of Small Animal Practice|January 13, 2025
Retrospective analysis of the incidence and clinicopathological findings associated with ammonium urate urolithiasis in dogs with congenital portosystemic shunts: 363 cases (2010-2023)M Walton-Clark, V Travail, T Sparks, et al.
Physical Review Letters|June 3, 2024
First Study of the ^{139}Ba(n,γ)^{140}Ba Reaction to Constrain the Conditions for the Astrophysical i ProcessA Spyrou, D Mücher, P A Denissenkov, et al.
Journal of Medicinal Chemistry|May 25, 2016
Diving into the Water: Inducible Binding Conformations for BRD4, TAF1(2), BRD9, and CECR2 BromodomainsTerry D Crawford, Vickie Tsui, E Megan Flynn, et al.
Pageof 30

Showing results (271-280 of 291) with videos related to

Sort By:
Pageof 30
Science (New York, N.Y.)|April 12, 2008
Aligning conservation priorities across taxa in Madagascar with high-resolution planning toolsC Kremen, A Cameron, A Moilanen, et al.
Journal of Medicinal Chemistry|October 4, 2012
Acyl guanidine inhibitors of β-secretase (BACE-1): optimization of a micromolar hit to a nanomolar lead via iterative solid- and solution-phase library synthesisSamuel W Gerritz, Weixu Zhai, Shuhao Shi, et al.
Journal of Medicinal Chemistry|October 15, 2016
Identification of (R)-N-((4-Methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide (CPI-1205), a Potent and Selective Inhibitor of Histone Methyltransferase EZH2, Suitable for Phase I Clinical Trials for B-Cell LymphomasRishi G Vaswani, Victor S Gehling, Les A Dakin, et al.
ACS Medicinal Chemistry Letters|February 20, 2018
Potent Inhibitors of Hepatitis C Virus NS3 Protease: Employment of a Difluoromethyl Group as a Hydrogen-Bond DonorBarbara Zheng, Stanley V D'Andrea, Li-Qiang Sun, et al.
Journal of Medicinal Chemistry|November 24, 2025
Discovery of CFT8634, a Potent, Selective, and Orally Bioavailable Heterobifunctional Degrader of BRD9Katrina L Jackson, Ning Yin, Roman V Agafonov, et al.
Bioorganic & Medicinal Chemistry Letters|October 7, 2011
Synthesis and in vivo evaluation of cyclic diaminopropane BACE-1 inhibitorsLorin A Thompson, Jianliang Shi, Carl P Decicco, et al.
Journal of Medicinal Chemistry|August 5, 2022
GNE-064: A Potent, Selective, and Orally Bioavailable Chemical Probe for the Bromodomains of SMARCA2 and SMARCA4 and the Fifth Bromodomain of PBRM1Alexander M Taylor, Chris Bailey, Lisa D Belmont, et al.
The Journal of Small Animal Practice|January 13, 2025
Retrospective analysis of the incidence and clinicopathological findings associated with ammonium urate urolithiasis in dogs with congenital portosystemic shunts: 363 cases (2010-2023)M Walton-Clark, V Travail, T Sparks, et al.
Physical Review Letters|June 3, 2024
First Study of the ^{139}Ba(n,γ)^{140}Ba Reaction to Constrain the Conditions for the Astrophysical i ProcessA Spyrou, D Mücher, P A Denissenkov, et al.
Journal of Medicinal Chemistry|May 25, 2016
Diving into the Water: Inducible Binding Conformations for BRD4, TAF1(2), BRD9, and CECR2 BromodomainsTerry D Crawford, Vickie Tsui, E Megan Flynn, et al.
Pageof 30